Allspring Global Investments Holdings, LLC Celcuity Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$5.35 - $10.11 $48,872 - $92,354	-9,135 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$7.93 - $13.33 $74,970 - $126,021	-9,454 Reduced 50.86%	9,135 $85,000
Q4 2021 Jan 28, 2022	BUY	$11.96 - $19.35 $222,324 - $359,697	18,589 New	18,589 $245,000

Others Institutions Holding CELC

# of Institutions

107

Shares Held

30.3M

Call Options Held

30.8K

Put Options Held

152K

Bvf Inc San Francisco, CA

3.47M
Shares

$44.1 Million
1.64% of portfolio
Perceptive Advisors LLC New York, NY

2.36M
Shares

$30.1 Million
0.92% of portfolio
Baker Bros. Advisors LP New York, NY

1.87M
Shares

$23.9 Million
0.3% of portfolio
Vanguard Group Inc Valley Forge, PA

1.63M
Shares

$20.7 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

1.54M
Shares

$19.5 Million
0.4% of portfolio

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $190M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account